The ability of this assay to detect FVIII activities of ˂1.00 IU/dl, as was measured in HPP 1 at all sites and in HPP 2 at Sheffield (Table 2), has beneficial clinical implications for severe hemophilia and indicates a high level of accuracy and precision. This evidence concerns the gene F8 and hemophilia.